INDV (Indivior Pharmaceuticals) Shiller PE Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INDV Indivior Pharmaceuticals Inc INDV
78 GF Score
Price $35.53
GF Value $24.67
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Indivior Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Indivior Pharmaceuticals  (NAS:INDV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Indivior Pharmaceuticals Shiller PE Ratio Related Terms


Indivior Pharmaceuticals Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Indivior Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Pharmaceuticals Shiller PE Ratio Chart

Indivior Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.55 16.05 17.53 23.63 73.08

Indivior Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.20 45.49 62.29 50.13 62.45

INDV vs AMLX, RGC, SUPN: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Indivior Pharmaceuticals's Shiller PE Ratio falls into.


INDV
78GF Score
Indivior Pharmaceuticals Inc INDV
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indivior Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Indivior Pharmaceuticals's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Indivior Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.9839/333.9520*333.9520
=0.984

Current CPI (Jun. 2026) = 333.9520.

Indivior Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -1.050 241.428 -1.452
201612 0.500 241.432 0.692
201703 0.550 243.801 0.753
201706 0.500 244.955 0.682
201709 0.350 246.819 0.474
201712 -1.000 246.524 -1.355
201803 0.600 249.554 0.803
201806 0.450 251.989 0.596
201809 0.611 252.439 0.808
201812 0.165 251.233 0.219
201903 0.436 254.202 0.573
201906 0.500 256.143 0.652
201909 0.300 256.759 0.390
201912 -0.376 256.974 -0.489
202003 -1.113 258.115 -1.441
202006 0.100 257.797 0.130
202009 0.050 260.280 0.064
202012 -0.089 260.474 -0.114
202103 0.512 264.877 0.645
202106 0.400 271.696 0.492
202109 0.150 274.310 0.183
202112 0.249 278.802 0.298
202203 0.275 287.504 0.320
202206 0.344 296.311 0.387
202209 0.280 296.808 0.315
202212 -1.341 296.797 -1.509
202303 0.312 301.836 0.345
202306 0.273 305.109 0.299
202309 -0.980 307.789 -1.064
202312 0.380 306.746 0.414
202403 0.445 312.332 0.476
202406 -0.719 314.175 -0.764
202409 0.165 315.301 0.175
202412 0.168 315.605 0.178
202503 0.376 319.799 0.393
202506 0.143 322.561 0.148
202509 0.326 324.800 0.335
202512 0.816 324.054 0.841
202603 0.690 330.213 0.698
202606 0.984 333.952 0.984

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Indivior Pharmaceuticals (INDV) Overvalued in 2026?

Based on GuruFocus' analysis, Indivior Pharmaceuticals stock appears to be overvalued. The current stock price of $35.53 is trading 44% above its estimated GF Value™ of $24.67. GuruFocus considers Indivior Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for INDV:

  • Shiller PE Ratio:
  • GF Value™: $24.67 vs. price of $35.53 (44% above fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the INDV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indivior Pharmaceuticals Business Description

Other Exchanges E7P:Germany
Address 10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
78GF Score

Get the complete analysis for INDV

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.53
Price
$24.67
GF Value